Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	780	406	108	125	256	297
Market Cap Growth	209.41%	277.18%	-14.15%	-50.96%	-14.02%	15.84%
Enterprise Value	723	377	85	117	226	284
Last Close Price	9.76	5.30	1.43	1.68	3.74	4.80
PE Ratio	45.35	47.50	-	-	-	-
Forward PE	65.07	50.28	-	-	-	-
PS Ratio	6.50	4.08	1.29	1.74	3.79	5.02
PB Ratio	12.13	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	12.20	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	37.26	33.99	15.45	-	-	-
P/OCF Ratio	36.77	33.54	15.13	-	-	-
EV/Sales Ratio	6.22	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	41.43	44.12	-	-	-	-
EV/EBIT Ratio	43.37	48.76	-	-	-	-
EV/FCF Ratio	34.54	31.54	12.17	-	-	-
Debt / Equity Ratio	0.05	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.18	0.27	-	-	-	-
Debt / FCF Ratio	0.16	0.22	0.47	-	-	-
Asset Turnover	1.60	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.27	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.16	2.96	1.57	1.61	1.89	1.17
Current Ratio	3.88	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	37.36%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	14.31%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Capital (ROIC)	20.56%	12.00%	-10.82%	-33.57%	-62.10%	-61.70%
Return on Capital Employed (ROCE)	24.10%	15.40%	-	-	-	-
Earnings Yield	2.27%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	2.68%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.13%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q